Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01488734 · ClinicalTrials.gov registry record · NA

Bioavailability and Biological Effects of Vitamin D2 Contained in Mushroom

A NA study, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
47
Enrollment target

NCT01488734 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 47 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01488734, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target

Study Summary

The purpose of this study is to compare the safety and efficacy of two different amounts of vitamin D2 (600 or 4000 International Units/day) provided by mushrooms added to one of the daily meals versus same doses of vitamin D3 provided as oral supplements sold in any drugstore in reaching adequate or optimal blood levels of 25(OH)D in people with Vitamin D deficiency and pre-diabetes (high blood sugar without full blown diabetes) or the metabolic syndrome. Metabolic syndrome is the name of a group of risk factors that raise the risk for heart disease and other health problems, such as diabetes and stroke as described by the US department of Health and Human Services. This study will also attempt to demonstrate and compare the effect of the intervention with above two doses of vitamin D on blood levels of tests that show inflammation.

Interventions

  • DRUG Placebo
  • DIETARY_SUPPLEMENT Mushroom with 600 IU vitamin D2
  • DIETARY_SUPPLEMENT Mushroom with 4000 IU Vitamin D2
  • DIETARY_SUPPLEMENT 600 IU Vitamin D3 and untreated mushroom
  • DIETARY_SUPPLEMENT 4000 IU Vitamin D3 and untreated mushroom

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2011-11
Est. Completion 2013-09
Phase NA

What the Registry Record Tells You About NCT01488734

The ClinicalTrials.gov registry entry for NCT01488734 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.

NCT01488734 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01488734 about?

NCT01488734 is a clinical study titled "Bioavailability and Biological Effects of Vitamin D2 Contained in Mushroom". The purpose of this study is to compare the safety and efficacy of two different amounts of vitamin D2 (600 or 4000 International Units/day) provided by mushrooms added to one of the daily meals versus same doses of vitamin D3 provided as oral supplements sold in any drugstore in reaching adequate o...

What is the current status of trial NCT01488734?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2011-11. Estimated completion is 2013-09.

What interventions are being tested in trial NCT01488734?

The interventions under investigation include: Placebo (DRUG), Mushroom with 600 IU vitamin D2 (DIETARY_SUPPLEMENT), Mushroom with 4000 IU Vitamin D2 (DIETARY_SUPPLEMENT), 600 IU Vitamin D3 and untreated mushroom (DIETARY_SUPPLEMENT), 4000 IU Vitamin D3 and untreated mushroom (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01488734?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.